Med Spa EBITDA Multiples in 2026: What Buyers Actually Value

Med spa EBITDA multiples are directional valuation benchmarks, not guaranteed sale prices. In 2026, a med spa’s multiple depends on adjusted EBITDA quality, revenue scale, provider dependence, recurring client demand, treatment mix, growth, compliance structure, equipment obligations, buyer type, financing conditions, and diligence findings.

Smaller owner-dependent practices are usually evaluated differently from multi-provider or multi-location med spas with clean financials, recurring revenue, stable medical director coverage, and transferable operations. The multiple is only one part of valuation; qualified buyers also evaluate deal structure, transition risk, working capital, and whether earnings can continue after closing.

Illustrative Multiple Assumptions—not Reported Market Data

The table below is a scenario framework, not a published comparable-transaction dataset, certified appraisal, or statement of typical 2026 outcomes. Each number must be treated as hypothetical unless supported by an identifiable transaction with a consistent earnings definition and disclosed deal structure.

These ranges are directional market context. They are not asking prices, guaranteed outcomes, certified appraisals, or aspirational targets.

What’s behind the ranges

A few observations about the structure of the data that matter for owners thinking about their own position:

The range within each tier is wide. A $1M EBITDA practice may be viewed very differently depending on risk, transferability, and buyer fit. Where you land inside a directional range is determined by the value drivers covered in what qualified med spa buyers evaluate: recurring revenue, service mix, owner concentration, growth, margin, and structural cleanliness.

Tier differences matter. Moving from “established single location” to “mature single location with low owner dependence” can materially change buyer interest. For many owners, the practical work is building injector depth, improving financial visibility, and shifting the owner from primary producer to strategic leader.

Multi-location scale can change the buyer pool. Crossing from a single high-performing location to a 3+ location group may support stronger buyer interest when operations, margins, staffing, and management depth are repeatable.

The very top of the market is selective. Large, multi-location, dermatology-anchored or platform-quality aesthetic businesses may receive stronger valuation treatment than smaller owner-dependent med spas, but only when earnings quality, management depth, and transferability support it.

How Buyer Type Can Change Underwriting

Buyer categories may evaluate the same med spa differently. A platform buyer may emphasize integration and management depth; a strategic operator may emphasize geography and service fit; an individual buyer may emphasize affordability and personal operating fit. Buyer identity does not establish a fixed multiple, and headline price must be evaluated alongside cash at close, rollover equity, earnouts, financing, working capital, and post-closing obligations.

How to Use Market Evidence

No official source provides a complete med spa multiple series, buyer-type range, vertical comparison, or fixed “turn” adjustment for memberships, growth, margin, ownership structure, or location count. Use identifiable transactions and normalized company-specific financials; do not extrapolate med spa values from broad healthcare-services statistics or sensitivity examples. Public claims should follow the FTC’s substantiation standard.

What’s not in this data

Three caveats worth flagging:

Distressed and quick-sale transactions. The ranges above are directional context for healthier practices in structured sale processes. Distressed transactions, fire sales, and quick liquidations can clear at meaningfully lower values.

Earnout-loaded structures. Some headline multiples include large earnout components that may or may not be paid. A “10x” sale where 6x is cash at close and 4x is contingent on hitting revenue targets two years out is not really a 10x sale. Headline multiples should always be reviewed against cash at close and contingent consideration.

International and offshore comparables. The data above is US-only. International med spa comparables (UK, Australia, Brazil, Mexico) reflect different regulatory environments and buyer pools and are not directly comparable.

Frequently asked questions

Why are single-location multiples lower than multi-location multiples for the same EBITDA?

Buyers pay for demonstrated repeatability. A multi-location group has proven its operating model can scale; a single-location practice has not. The platform premium is real and reflects buyer preference for businesses they can plug into existing infrastructure.

Can med spas receive 14x+ EBITDA multiples?

Possibly, but any such outcome is transaction-specific. It should not be described as a current market benchmark without an identifiable comparable showing the earnings definition, consideration structure, transaction date, and business profile.

How much do multiples vary by geography?

Less than you might expect. Major coastal markets may receive modestly stronger buyer interest than some secondary markets because of competition density and patient demographics, but geography rarely outweighs earnings quality, provider continuity, and transferability.

What if I’m being offered a multiple lower than the range above?

The most common reasons are buyer-specific risk concerns, weak documentation, owner dependence, deal-structure issues, or a single-buyer offer that has not been tested against broader market feedback. The fix is understanding what qualified buyers may evaluate before treating one offer as the market.

Related Questions Med Spa Owners Ask

Why do two med spas with similar EBITDA receive different multiples?

Buyers price the durability and transferability of earnings. Memberships, diversified treatments, stable providers, clean compliance, and low owner dependence can support stronger demand.

Do strategic buyers always pay more?

No. A strategic buyer may recognize synergies, but only when the location, team, services, and management-services structure fit its platform.

How are memberships reflected in value?

Buyers examine retention, utilization, discounting, deferred obligations, and revenue concentration. Predictable recurring revenue helps only when the program is economically sound.

Can device ownership increase the multiple?

Sometimes, but devices are assessed alongside utilization, remaining useful life, leases, liens, maintenance, and replacement needs. Expensive equipment is not automatically valuable.

Are listed multiple ranges guaranteed?

No. The ranges and examples on this page are directional or hypothetical and require validation against normalized financials, deal terms, and current buyer demand.

---

Related reading:

• How Much Is My Med Spa Worth? A 2026 Valuation Guide
• What Med Spa Buyers Actually Look For
• Confidential Med Spa Sale Process
• Confidential Conversation